Spondylitis, Ankylosing Clinical Trial
Official title:
Tai Chi in Patients With Ankylosing Spondylitis
Verified date | January 2020 |
Source | Pamukkale University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Ankylosing Spondylitis (AS) is a chronic inflammatory rheumatic disease that causes a
decrease in physical activity, fatigue, sleep problems and psychological consequences such as
depression, anxiety and stress by primarily affecting the sacroiliac joint and spine. The aim
of the treatment of AS is to prevent the hardness and flexion deformity associated with the
disease; to maintain the patient's healthy psychological and physical condition. The first
step in the treatment of AS; Pharmacological treatment of NSAIDs or Anti-TNFs along with
exercise. Exercise, especially pain and immobility symptoms control provides patients with
disease is an advantage.
Tai Chi Chuan or Taiji is a traditional Chinese exercise method that has been applied for
more than 300 years. Exercises based on Chinese medicine and martial arts. It is a
combination of physical exercise and relaxation techniques and is used to improve the mental
and physical health of individuals. In literature, balance, strength, coordination, postural
control, agility, reaction time, flexibility has attracted attention for developing such
factors. In addition, it increases muscle strength in elderly people and decreases the risk
of falling; Rheumatoid arthritis and Osteoarthritis-related symptoms have been reported to
improve in a positive way. In the literature, there is only one study examining the efficacy
of Tai Chi in AS patients. According to the results of this study, Tai Chi has a positive
effect on disease activity and flexibility of patients with AS.
Although there is consensus on exercise role in the treatment of AS, when the literature is
reviewed, it is seen that the strict and definite guidelines on the type and frequency of
exercises are not yet described. There is no defined protocol for which specific exercise is
appropriate in AS. The literature considers that more information is needed on the various
physical therapy programs related to intensity, frequency and duration to determine the most
appropriate activity for the disease.
The aim of this study was to investigate the effect of Tai Chi exercises on functionality,
disease activity, functional exercise capacity, spinal mobility, lower extremity strength and
quality of life in AS patients with biological agents.
Status | Completed |
Enrollment | 36 |
Est. completion date | April 30, 2019 |
Est. primary completion date | April 30, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Being sedentary (not routinely involved in exercise activities during the last 3 months). - We have been using fixed dose medication for at least 6 months (no change in drug treatment during the study). - No communication problem Exclusion Criteria: - Functional disorders more effective than ankylosing spondylitis; - Diastolic heart failure - Renal failure - Severe asthma knee osteoarthritis - Metastatic prostate cancer |
Country | Name | City | State |
---|---|---|---|
Turkey | Antalya Education and Research Hospital | Antalya | Konyaalti |
Lead Sponsor | Collaborator |
---|---|
Pamukkale University |
Turkey,
Lee EN, Kim YH, Chung WT, Lee MS. Tai chi for disease activity and flexibility in patients with ankylosing spondylitis--a controlled clinical trial. Evid Based Complement Alternat Med. 2008 Dec;5(4):457-62. doi: 10.1093/ecam/nem048. Epub 2007 Jul 13. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Bath Ankylosing Spondylitis Functional Index (BASFI) | This self-assessment instrument was designed by a team of medical professionals in conjunction with patients, and consists of 8 specific questions regarding function in AS and 2 questions reflecting the patient's ability to cope with everyday life. Each question is answered on a 10 cm horizontal visual analog scale, the mean of which gives the BASFI score (0-10). Higher scores show poor functionality. | ten weeks | |
Primary | Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) | The index, designed by a multidisciplinary team with input from patients, consists of six 10 cm horizontal visual analog scales to measure severity of fatigue, spinal and peripheral joint pain, localized tenderness and morning stiffness (both qualitative and quantitative). The final BASDAI score has a range of 0 to 10. Higher scores show poor disease activity. | ten weeks | |
Primary | Bath Ankylosing Spondylitis Metrology Index (BASMI) | It is for quantify the mobility of the axial skeleton in ankylosing spondylitis (AS) patients and allow objective assessment of clinically significant changes in spinal movement.It is included of clinical measures of cervical rotation, tragus to wall distance, lumbar flexion, lumbar side flexion, and intermalleolar distance.Each item is scored from 0-10 based on individually defined cut points. Ranges are given as cervical rotation (>85.0° to =8.5°), tragus to wall (<10 cm to =38 cm), lumbar flexion (>7.0 cm to =0.7 cm), lumbar side flexion (>20.0 cm to <1.2 cm), and intermalleolar distance (=120 cm to <30 cm). Higher scores show poor spinal mobility. | ten weeks | |
Secondary | Ankylosing Spondylitis Life Quality Questionnaire (ASQol), | It is purpose to measure the impact of ankylosing spondylitis (AS) on health-related quality of life from the patient's perspective.The questionnaire includes items related to the impact of disease on sleep, mood, motivation, coping, activities of daily living, independence, relationships, and social life. It is included 18 items.Dichotomous responses, with 0 scored for a "no" and 1 scored for a "yes" for each item. Total score is the sum of the individual responses.Score range is 0-18, with higher scores reflecting greater impairment of health-related quality of life. | ten weeks | |
Secondary | 6 minute walking test | The maximum distance that individuals can walk in a 30-meter straight and inclined corridor for 6 minutes is recorded. Higher distances show better aerobic capacity | ten week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01208207 -
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
|
Phase 3 | |
Completed |
NCT02509026 -
Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA
|
Phase 4 | |
Completed |
NCT02704845 -
Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain
|
N/A | |
Terminated |
NCT01209702 -
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Ankylosing Spondylitis Who Have Failed Treatment With NSAIDs
|
Phase 3 | |
Terminated |
NCT01209689 -
A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy
|
Phase 3 | |
Terminated |
NCT00766402 -
An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the Treatment of Pain in Participants With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)
|
Phase 4 | |
Completed |
NCT00000433 -
Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
|
Phase 2 | |
Completed |
NCT00779012 -
A Study of the Efficacy and Tolerance of Remicade in the Treatment of Active Ankylosing Spondylitis (Study P04042)(COMPLETED)
|
Phase 4 | |
Completed |
NCT00779935 -
Growth Factor Concentration to Predict an Ankylosing Spondylitis Patient's Response to Infliximab (Study P04041)(COMPLETED)
|
Phase 4 | |
Completed |
NCT01863732 -
Extension in AS: Sustainability of Benefits, Safety and Tolerability
|
Phase 3 | |
Recruiting |
NCT05879419 -
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
|
Phase 4 | |
Completed |
NCT01567878 -
Ultrasound of Enthesis in Patients With Ankylosing Spondylitis: a Comparative Study With Health Subjects
|
N/A | |
Completed |
NCT01188655 -
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
|
N/A | |
Completed |
NCT00760669 -
An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
|
Phase 4 | |
Completed |
NCT02159053 -
16-week Efficacy and 2-year Safety, Tolerability and Efficacy of Secukinumab in Participants With Active Ankylosing Spondylitis
|
Phase 3 | |
Completed |
NCT00202865 -
Evaluation of Low Dose Infliximab in Ankylosing Spondylitis (Study P04352)
|
Phase 3 | |
Completed |
NCT02374502 -
Increasing Physical Activity in Ankylosing Spondylitis: a Randomised Controlled Trial
|
N/A | |
Withdrawn |
NCT00298012 -
Methotrexate in the Treatment of Axial Spondyloarthritis
|
Phase 4 | |
Terminated |
NCT00273858 -
Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis
|
N/A | |
Completed |
NCT04810715 -
Frequency of Pes Planus and Posterior Tibial Tendon Dysfunction in Patients With Ankylosing Spondylitis
|